COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
72.92 EUR
-0.94 (-1.27%)
CBHD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. CBHD has an excellent profitability rating, but there are some minor concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate. Finally CBHD also has an excellent dividend rating. This makes CBHD very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
In the past year CBHD had a positive cash flow from operations.
In the past 5 years CBHD has always been profitable.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
CBHD has a Return On Assets of 7.52%. This is amongst the best in the industry. CBHD outperforms 81.54% of its industry peers.
The Return On Equity of CBHD (22.55%) is better than 89.23% of its industry peers.
CBHD has a better Return On Invested Capital (12.65%) than 92.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is above the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD has a Profit Margin of 13.04%. This is in the better half of the industry: CBHD outperforms 73.85% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
The Operating Margin of CBHD (27.52%) is better than 95.38% of its industry peers.
CBHD's Operating Margin has declined in the last couple of years.
CBHD has a Gross Margin of 67.97%. This is in the better half of the industry: CBHD outperforms 73.85% of its industry peers.
In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
Compared to 1 year ago, CBHD has about the same amount of shares outstanding.
Compared to 5 years ago, CBHD has more shares outstanding
CBHD has a better debt/assets ratio than last year.
2.2 Solvency
CBHD has an Altman-Z score of 3.84. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.84, CBHD is doing good in the industry, outperforming 67.69% of the companies in the same industry.
The Debt to FCF ratio of CBHD is 4.34, which is a neutral value as it means it would take CBHD, 4.34 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.34, CBHD is in line with its industry, outperforming 58.46% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CBHD (1.24) is worse than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.84 |
ROIC/WACC2.22
WACC5.69%
2.3 Liquidity
CBHD has a Current Ratio of 1.61. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Current ratio of 1.61. This is comparable to the rest of the industry: CBHD outperforms 47.69% of its industry peers.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Quick ratio (1.00) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.93%.
Measured over the past years, CBHD shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.02% on average per year.
CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.49% on average per year.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.78% on average per year.
CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.08% yearly.
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 30.64, the valuation of CBHD can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CBHD.
Compared to an average S&P500 Price/Earnings ratio of 26.50, CBHD is valued at the same level.
CBHD is valuated rather expensively with a Price/Forward Earnings ratio of 20.88.
The rest of the industry has a similar Price/Forward Earnings ratio as CBHD.
CBHD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.93, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.64 | ||
| Fwd PE | 20.88 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.94 | ||
| EV/EBITDA | 14.93 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBHD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CBHD's earnings are expected to grow with 21.46% in the coming years.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y21.46%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.23%, CBHD is a good candidate for dividend investing.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.03. CBHD pays more dividend than 98.46% of the companies in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.23% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
FRA:CBHD (12/23/2025, 7:00:00 PM)
72.92
-0.94 (-1.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap15.33B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70
Price Target92.6 (26.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.23% |
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)0.64%
PT rev (3m)-2.26%
EPS NQ rev (1m)3.45%
EPS NQ rev (3m)17.67%
EPS NY rev (1m)0.81%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)2.61%
Revenue NQ rev (3m)8.83%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.64 | ||
| Fwd PE | 20.88 | ||
| P/S | 4.11 | ||
| P/FCF | 21.94 | ||
| P/OCF | 17.23 | ||
| P/B | 7.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.93 |
EPS(TTM)2.38
EY3.26%
EPS(NY)3.49
Fwd EY4.79%
FCF(TTM)3.32
FCFY4.56%
OCF(TTM)4.23
OCFY5.8%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.65
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.84 |
F-Score6
WACC5.69%
ROIC/WACC2.22
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.63%
EBIT Next 3Y14.66%
EBIT Next 5Y12.28%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.87% in the next year.